Skip to main content
The SciencePricingJournal

WITHDRAWAL SCIENCE

Why you keep relapsing has a neurobiological answer.

It is not willpower. It is receptor chemistry. Nicotine, cannabis, and alcohol withdrawal are not the same phenomenon. They operate through different systems, produce different symptoms, and require different interventions.

70-80%

of people relapse in week one

Weeks 2-4

the second and deadlier relapse window

The only

common withdrawal that can be fatal

† Sources: NIDA, DSM-5, and clinical withdrawal literature.

Start with The Nicotine Story

Why every other cessation product treats a neurochemical problem like a behavioral one.

Nicorette replaces nicotine. It does not address receptor upregulation.

Smoke Free tracks your streak. It does not ship anything to your body.

Cold turkey provides no neurochemical support for the biology it disrupts.

Chantix works on one receptor system for one substance.

AA addresses the social and psychological dimensions of alcohol dependence.

None of these are wrong. They are all incomplete.

The problem is not that people lack willpower. The problem is that withdrawal is a receptor-level biological event and most cessation tools operate above that level.

PATCHESAPPSCOLD TURKEYRELAPSD
Addresses receptor upregulation×××
Substance-specific protocol×××
Ships physical support monthly×××
Sleep protocol for cannabis withdrawal×××
Adapts to your craving data××
Medical safety screening×××
Supports the dopamine deficit (weeks 2-4)×××

This is not a claim against other approaches. It is a statement about what withdrawal biology requires.

THE NICOTINE STORY

Receptor system: nAChRs. The same reward circuitry as food, sex, and social bonding.

HOW NICOTINE REWIRES THE BRAIN

Nicotine mimics acetylcholine - a neurotransmitter your brain already uses - and binds to nicotinic acetylcholine receptors (nAChRs). Each binding triggers a dopamine surge roughly 200% above baseline.

Your brain is not broken. It is responding exactly as designed to a molecule that hijacks its most fundamental reward signal.

Over weeks and months, the brain compensates: it creates more nAChRs and makes existing ones more sensitive. This is upregulation. By the time you decide to quit, you have more receptors than a non-user - and all of them are waiting for a signal that isn't coming.

That waiting state is a craving.

BEFOREnon-user, baseline densityAFTERchronic use, upregulated

THE SECOND RELAPSE WINDOW

Most people fail in week one from physical craving. The ones who get past that fail in weeks 2-4 for a different reason.

When nicotine is removed, your dopamine system - which has been outsourcing its dopamine production to nicotine for months - falls below its pre-addiction baseline. Not just 'less happy.' Neurochemically below the set-point that makes normal activities feel rewarding.

This is why former smokers in week three describe feeling flat, unmotivated, and vaguely depressed. It is not psychological weakness. It is the dopamine system recalibrating.

Most people reach for a vape to 'fix' the feeling. The fix works instantly. The problem restarts immediately.

THE NIC WITHDRAWAL TIMELINE

20 MINHeart rate normalizesBlood pressure begins falling toward baseline. Circulation improves.
2-12 HRSPeak craving onsetBlood nicotine levels dropping. Unoccupied nAChRs begin signaling.
HIGH RELAPSE RISK
72 HRSNicotine fully clearedMaximum receptor unoccupancy. Most dangerous relapse window. The physical peak.
WEEK 1-2Physical symptoms subsideAcute withdrawal passing. Taste and smell returning. Don't mistake this for being through it.
HIGH RELAPSE RISK
WEEKS 2-4Dopamine deficitThe second relapse window. Anhedonia, flat mood, low motivation. Neurochemical, not psychological.
MONTH 1-3Receptor normalizationnAChR density gradually reducing toward baseline. Cravings become episodic.
6-12 MOBaseline restoredReceptor density and dopamine largely normalized. Cue-triggered cravings remain but diminish.

THE CANNABIS STORY

Receptor system: CB1. The endocannabinoid system governs sleep, appetite, mood, memory, and stress. All at once.

WHAT MAKES THIS DIFFERENT FROM NICOTINE

Cannabis withdrawal is not better or worse than nicotine withdrawal. It is a completely different biological event.

Nicotine withdrawal is primarily about dopamine and receptor signaling. Cannabis withdrawal is about the endocannabinoid system - your brain's master regulatory network - losing its primary input.

The symptoms are not similar. The timeline is not similar. The intervention is not similar. This is why a protocol built for nicotine does nothing for cannabis.

CB1 RECEPTOR SYSTEMTHCanandamideSLEEPAPPETITEMOODSTRESS

THE SLEEP CRISIS

This is the reason most people go back.

THC suppresses REM sleep. During use, your brain spends less time in the rapid eye movement phase that processes emotion and consolidates memory. Your brain adapts to this suppression as its new normal.

When THC is removed, the brain overcorrects: REM rebound. More REM sleep, more intense REM sleep, and more vivid - often disturbing - dreams than most people have ever experienced.

Night 3, 4, and 5 are typically the worst. Some users describe them as nightmares. They are not. They are memory consolidation processes that have been dammed for months, finally releasing.

Most people do not know this is coming. Most cessation programs do not address it. The GREEN protocol starts with sleep support on day one, because the insomnia does not wait.

DURING USE - SUPPRESSED REMREMDAYS 3-7 - REM REBOUNDREM REBOUND

The intensity normalizes in weeks 2-3. The protocol manages the acute phase.

THE GREEN WITHDRAWAL TIMELINE

DAY 1-3Irritability and anxietyNervous system recalibrating without CB1 input. Earliest sleep disruption begins.
HIGH RELAPSE RISK
DAYS 3-7Peak acute withdrawalSevere insomnia. REM rebound begins. Vivid or disturbing dreams. Night sweats. Peak anxiety.
WEEK 2Sleep slowly improvingDream intensity decreasing. Appetite returning. Anxiety beginning to stabilize.
WEEKS 3-6CB1 sensitivity recoveringMood stabilizing. Cognitive fog lifting. Processing speed returning.
MONTHS 1-3Full recoveryEmotional regulation restored. Sleep normalized. Cognitive function fully returned for moderate users.
MEDICAL SAFETY NOTE

Alcohol withdrawal is the only common substance withdrawal that can be medically serious. In heavy daily drinkers (8+ drinks per day), stopping without medical supervision carries risk of seizures and delirium tremens. If this describes your use, consult a physician before starting any cessation protocol. Relapsd is designed for mild to moderate drinkers and post-detox maintenance.

THE ALCOHOL STORY

Receptor systems: GABA-A and NMDA. The only common withdrawal that can be life-threatening.

THE IMBALANCE

Alcohol is a CNS depressant. It works by enhancing GABA-A receptors (the brain's 'calm down' signal) and suppressing NMDA receptors (the brain's 'activate' signal).

The brain compensates for this artificial calming: GABA-A receptors become less responsive. NMDA receptors become more sensitive.

Now alcohol is removed.

The inhibitory system is under-active. The excitatory system is over-active. The result is the opposite of alcohol's effects: hyperexcitability, anxiety, tremors, and in severe cases, seizures.

This is why alcohol withdrawal is medically different from every other cessation experience. It is not about craving. It is about your nervous system losing its chemical anchor.

GABANMDADURING USEGABANMDAWITHDRAWALGABANMDARECOVERY
THE B-VITAMIN DEPLETION NOBODY TALKS ABOUT

Chronic alcohol use impairs thiamine (B1) absorption and increases its excretion. Thiamine deficiency at severe levels causes Wernicke's encephalopathy - irreversible neurological damage affecting memory and coordination.

This is not rare in heavy alcohol users. It is common enough that every serious alcohol recovery protocol must address B-vitamin repletion before anything else. The Relapsd DRY protocol loads B vitamins in the three days before the quit date.

This is why alcohol cessation is not just about stopping drinking. It is about rebuilding the nutritional infrastructure that alcohol depleted.

THE DRY WITHDRAWAL TIMELINE
6-24 HRSAcute onsetAnxiety, tremors, sweating, elevated heart rate. GABA-A hypersensitivity manifesting.
HIGH RELAPSE RISK
24-48 HRSPeak acute riskSeizure risk window for heavy users. Hallucinations in severe dependence.
HIGH RELAPSE RISK
48-72 HRSDTs risk windowDelirium tremens risk (rare but serious). Medical supervision critical for heavy users.
WEEKS 1-2Physical subsidingAcute symptoms resolving. Fatigue, insomnia, and depression emerging.
WEEKS 2-8PAWS beginsPost-Acute Withdrawal Syndrome. Mood instability, cognitive fog, sleep disruption. Can persist months.
MONTHS 1-6System restorationGABA-A and NMDA receptor density normalizing. Dopamine system recovering. Thiamine levels restoring.

THE COMPOUNDS

What the research points to - and why.

These are not supplements chosen because they sound credible. Every compound below has a documented mechanism, studied doses, and a specific rationale tied to the withdrawal biology above.

NICGREENDRY
5+ RCTs

N-Acetylcysteine (NAC)

600mg twice daily


Glutamate homeostasis restoration

NAC restores function of the cystine-glutamate antiporter (system xCT) in the nucleus accumbens. Substance use suppresses this transporter, causing pathological glutamate signaling that drives compulsive use behavior.

WHY THIS SUBSTANCE

Every substance studied here - nicotine, cannabis, and alcohol - dysregulates the glutamate system. NAC is the only compound with evidence across all three. It also provides hepatoprotection directly relevant to alcohol recovery.


Three randomized controlled trials show NAC reduces cannabis use and craving. One double-blind RCT showed significant reduction in tobacco use. NAC is the primary treatment for acetaminophen-induced liver failure - its hepatoprotective mechanism is among the most studied in clinical medicine.

NIC
12 RCTs

Cytisine

1.5mg, titrated schedule


Partial agonist at alpha4beta2 nAChRs

Cytisine occupies nicotinic acetylcholine receptors with lower intrinsic activity than nicotine. It reduces craving by partially satisfying receptor signaling while blocking nicotine's full reward effect if relapse occurs. The mechanism is identical to varenicline (Chantix) but cytisine is plant-derived.

WHY THIS SUBSTANCE

nAChR upregulation is the defining mechanism of nicotine addiction. Cytisine directly addresses this mechanism at the receptor level rather than managing symptoms downstream.


Cytisine has been used as a cessation aid in Eastern Europe since the 1960s. A 2011 New England Journal of Medicine trial found it more effective than nicotine replacement therapy. It remains largely unknown in the US market.

GREEN
ECS research

Omega-3 DHA/EPA

2000mg (EPA 180mg + DHA 120mg)


Endocannabinoid substrate restoration

The brain's endocannabinoids - anandamide and 2-AG - are synthesized from fatty acid precursors. DHA and EPA are required substrates for this synthesis. Chronic THC use depletes endogenous cannabinoid production capacity.

WHY THIS SUBSTANCE

Supplementing the raw materials for endocannabinoid synthesis directly supports ECS recovery. This is specific to cannabis withdrawal in a way that no other common supplement is. It is why the Omega-3 is in the GREEN protocol and not the others.


This is the only compound in the protocol whose rationale is unique to cannabis. No other substance withdrawal creates the specific deficit in endocannabinoid substrate that THC use produces.

GREEN
BBB studies

Magnesium L-Threonate

2000mg


Blood-brain barrier magnesium delivery

Magnesium L-Threonate is the only magnesium form demonstrated to cross the blood-brain barrier effectively. Once there, it supports NMDA receptor function and has been specifically studied for sleep quality and cognitive function restoration.

WHY THIS SUBSTANCE

Cannabis withdrawal's two defining features - insomnia and cognitive fog - are directly addressed by this compound. Standard magnesium forms do not reach the brain at therapeutic concentrations. This form does.


A 2016 study in Neuropharmacology showed Magnesium L-Threonate significantly improved sleep quality and reduced anxiety in subjects with suboptimal magnesium levels. The BBB penetration data distinguishes it from every other magnesium supplement.

DRY
3 clinical trials

Kudzu Root (Pueraria Lobata)

1500mg


Mesolimbic dopamine modulation

Kudzu root isoflavones modulate dopaminergic and serotonergic systems in the mesolimbic reward pathway. Three clinical trials specifically show significant reduction in alcohol consumption and craving. It reduces the reward value of alcohol, not just the craving.

WHY THIS SUBSTANCE

Alcohol addiction involves the mesolimbic dopamine system just as nicotine does - but the intervention mechanism is different. Kudzu operates on this system through a different pathway than nicotine-targeted compounds.


A 2005 Harvard Medical School study found that kudzu extract reduced alcohol consumption by 34-57% in heavy drinkers over a short-term period without behavioral intervention. This is the most clinically studied natural compound specifically for alcohol use.

GREEN
GABA-A research

Apigenin

50mg


GABA-A positive allosteric modulation

Apigenin acts as a positive allosteric modulator of GABA-A receptors - the same mechanism as benzodiazepines, but without the potency, tolerance risk, or dependency potential. It is the anxiolytic option with the best safety profile for recovery use.

WHY THIS SUBSTANCE

Cannabis withdrawal produces acute anxiety through CB1 deficiency. GABA-A support addresses this anxiety biochemically without introducing a second dependency risk. This is why apigenin rather than any prescription anxiolytic is in the GREEN protocol.


Apigenin is found naturally in chamomile. Its GABA-A modulation is well-documented. Unlike benzodiazepines, no tolerance or withdrawal syndrome has been observed at standard doses in research settings.

THE 8-WEEK PROTOCOL

Not a detox. A structured biological recovery arc.

Different for every substance. Timed to the actual neurochemical timeline.

NIC PROTOCOL

WEEKS 1-2: Receptor management

Start support before the quit day. Begin reducing nicotine exposure while the protocol manages receptor signaling.

WEEKS 3-4: Behavioral transfer

Quit nicotine entirely. Oral tools carry the behavioral habit while the receptor system recalibrates.

WEEKS 5-6: Dopamine support

The second relapse window. Mood Bridge compounds address the dopamine deficit before it becomes a relapse trigger.

WEEKS 7-8: Taper and maintenance

Supplement taper. Behavioral tools and the app remain active. Protocol completion milestone.

GREEN PROTOCOL

WEEK 1: Sleep crisis management

Start the Sleep Protocol immediately. The insomnia is coming whether you prepare or not. The protocol prepares.

WEEKS 1-2: ECS substrate loading

DHA/EPA and NAC begin supporting endocannabinoid system recovery. Craving support for the acute phase.

WEEKS 3-6: CB1 sensitivity recovery

Mood and cognitive function improving. Adaptogen support for HPA axis stabilization as anxiety subsides.

WEEKS 7-8: Cognitive restoration

Brain Recovery compounds continue. Cognitive function measurably improving. Sleep quality documented as the baseline.

DRY PROTOCOL

PRE-START: B-vitamin loading

3 days before quit date, begin thiamine and B-complex at therapeutic doses. Medical screening completed.

WEEKS 1-2: Acute phase

Full DRY stack. 3x daily app check-ins. Gut repair begins. Liver support active. PAWS awareness monitoring.

WEEKS 3-6: PAWS management

GABA stabilization continuing. Gut and liver recovery ongoing. Mood tracking to detect PAWS onset early.

WEEKS 7-8: Maintenance

B-vitamin and liver support continue indefinitely. Long-term recovery tracked in the app.

THE DIFFERENCE

Most people who quit cold turkey are not wrong to try. They are going into a biological event without biological support.

What changes when you have the right protocol:

You know week two is coming before it arrives.
You understand that the flat mood in week three is neurochemical, not psychological, and it has a timeline.
Your sleep crisis has a plan before night one.
The supplement stack targets the specific receptor system your substance disrupted.
If you relapse, the data is preserved and the protocol adjusts.

You are not trying harder. You are trying with the right tools.

The protocol starts with assessment.

Seven steps. No card required. Your substance, your usage, your history - built into a protocol that is not someone else's.

Start The Free Assessment ->

Plans from $79/month after assessment. Cancel anytime.

QUESTIONS

What people search when they are in it.

FREQUENTLY ASKED